Skip to main content

Table 2 Results of base case cost-effectiveness analysis

From: Offering a lifestyle intervention to women of premenopausal age as primary prevention for cardiovascular disease? – assessing its cost-effectiveness

 

Lifestyle modification

Usual care

Difference

ICER

Total cost

$8133

$6743

$1389

QALY

18.070

18.057

0.0128

$108,801/QALY

LY

23.084

23.074

0.0094

$147,941/LY

Cost of intervention

$1560

$0

$1560

 

Cost of CVD-related hospitalisation

$904

$928

-$24

 

Cost of CVD management

$5568

$5732

-$164

 

Number of first ever CVD eventsa

1000

1019

-19

 

 Myocardial infarction

339

346

-7

 

 Unstable angina

154

156

-2

 

 Ischaemic stroke

147

150

−3

 

 Haemorrhagic stroke

42

43

−1

 

 Transient ischaemic attack

75

77

−2

 

 PVD

56

56

0

 

 Congestive heart failure

117

120

−3

 

 Other CHD

49

50

−1

 

 Other CVD death

21

21

0

 

Number of recurrent CVD events

711

734

−23

 

 Nonfatal stroke

182

187

−5

 

 Nonfatal myocardial infarction

209

219

−10

 

 CVD death

320

328

−8

 
  1. QALY quality-adjusted life year, LY life year, ICER incremental cost-effectiveness ratio, CVD cardiovascular disease, CHD coronary heart disease, PVD peripheral vascular disease
  2. aper 10,000 patients